OR WAIT null SECS
© 2021 MJH Life Sciences and Medical Economics. All rights reserved.
© 2021 MJH Life Sciences™ and Medical Economics. All rights reserved.
Older patients started on oral antidiabetic therapy with a sulfonylurea have significantly higher risk for cardiovascular disease (CVD) events than patients started on metformin.